期刊
VETERINARY MICROBIOLOGY
卷 176, 期 3-4, 页码 292-300出版社
ELSEVIER
DOI: 10.1016/j.vetmic.2015.01.015
关键词
Gentamicin sulfate; Aminoglycoside; Foal; Horse; Liposomes; Macrophage
资金
- Grayson Jockey Club Research Foundation
Rhodococcus equi, a facultative intracellular pathogen and an important cause of pneumonia in foals, is highly susceptible to killing by gentamicin in vitro. However, gentamicin is not effective in vivo, due to its poor cellular penetration. Encapsulation of drugs in liposomes enhances cellular uptake. The objectives of this study were to compare liposomal gentamicin and free gentamicin with respect to their uptake by equine macrophages and intracellular colocalization with R. equi and to compare the efficacies of liposomal gentamicin, free gentamicin and clarithromycin with rifampin for the reduction of R. equi CFU in a mouse model of infection. After ex vivo exposure, a significantly higher mean (+/- SD) percentage of equine alveolar macrophages contained liposomal gentamicin (91.9 +/- 7.6%) as opposed to free gentamicin (16.8 +/- 12.5%). Intracellular colocalization of drug and R. equi, as assessed by confocal microscopy, occurred in a significantly higher proportion of cells exposed to liposomal gentamicin (81.2 +/- 17.8%) compared to those exposed to free gentamicin (10.4 +/- 8.7%). The number of R. equi CFU in the spleen was significantly lower in mice treated with liposomal gentamicin compared to that of mice treated with free gentamicin or to untreated control mice. Treatment with liposomal gentamicin also resulted in a significantly greater reduction in the number of R. equi CFU in the liver compared to treatment with clarithromycin in combination with rifampin. These results support further investigation of liposomal gentamicin as a new treatment for infections caused by R. equi. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据